402 related articles for article (PubMed ID: 30157918)
1. SP1-induced lncRNA AGAP2-AS1 expression promotes chemoresistance of breast cancer by epigenetic regulation of MyD88.
Dong H; Wang W; Mo S; Chen R; Zou K; Han J; Zhang F; Hu J
J Exp Clin Cancer Res; 2018 Aug; 37(1):202. PubMed ID: 30157918
[TBL] [Abstract][Full Text] [Related]
2. Increased Expression of Exosomal AGAP2-AS1 (AGAP2 Antisense RNA 1) In Breast Cancer Cells Inhibits Trastuzumab-Induced Cell Cytotoxicity.
Zheng Z; Chen M; Xing P; Yan X; Xie B
Med Sci Monit; 2019 Mar; 25():2211-2220. PubMed ID: 30910994
[TBL] [Abstract][Full Text] [Related]
3. Activation of LncRNA TINCR by H3K27 acetylation promotes Trastuzumab resistance and epithelial-mesenchymal transition by targeting MicroRNA-125b in breast Cancer.
Dong H; Hu J; Zou K; Ye M; Chen Y; Wu C; Chen X; Han M
Mol Cancer; 2019 Jan; 18(1):3. PubMed ID: 30621694
[TBL] [Abstract][Full Text] [Related]
4. EIF4A3 stabilizes the expression of lncRNA AGAP2-AS1 to activate cancer-associated fibroblasts via MyD88/NF-κb signaling.
Xu Q; Zhao T; Han H; Fan J; Xie W
Thorac Cancer; 2023 Feb; 14(5):450-461. PubMed ID: 36541122
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA SNHG14 induces trastuzumab resistance of breast cancer via regulating PABPC1 expression through H3K27 acetylation.
Dong H; Wang W; Mo S; Liu Q; Chen X; Chen R; Zhang Y; Zou K; Ye M; He X; Zhang F; Han J; Hu J
J Cell Mol Med; 2018 Oct; 22(10):4935-4947. PubMed ID: 30063126
[TBL] [Abstract][Full Text] [Related]
6. MSC-induced lncRNA AGAP2-AS1 promotes stemness and trastuzumab resistance through regulating CPT1 expression and fatty acid oxidation in breast cancer.
Han J; Qu H; Han M; Ding Y; Xie M; Hu J; Chen Y; Dong H
Oncogene; 2021 Jan; 40(4):833-847. PubMed ID: 33273726
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding AGAP2-AS1 is activated by SP1 and promotes cell proliferation and invasion in gastric cancer.
Qi F; Liu X; Wu H; Yu X; Wei C; Huang X; Ji G; Nie F; Wang K
J Hematol Oncol; 2017 Feb; 10(1):48. PubMed ID: 28209205
[TBL] [Abstract][Full Text] [Related]
8. Role of lncRNA AGAP2-AS1 in Breast Cancer Cell Resistance to Apoptosis by the Regulation of MTA1 Promoter Activity.
Wu M; Wen L; Zhou Y; Wu W
Technol Cancer Res Treat; 2022; 21():15330338221085361. PubMed ID: 35369814
[No Abstract] [Full Text] [Related]
9. Exosome-mediated lncRNA AFAP1-AS1 promotes trastuzumab resistance through binding with AUF1 and activating ERBB2 translation.
Han M; Gu Y; Lu P; Li J; Cao H; Li X; Qian X; Yu C; Yang Y; Yang X; Han N; Dou D; Hu J; Dong H
Mol Cancer; 2020 Feb; 19(1):26. PubMed ID: 32020881
[TBL] [Abstract][Full Text] [Related]
10. SP1 induced long non-coding RNA AGAP2-AS1 promotes cholangiocarcinoma proliferation via silencing of CDKN1A.
Ji H; Wang J; Lu B; Li J; Zhou J; Wang L; Xu S; Peng P; Hu X; Wang K
Mol Med; 2021 Feb; 27(1):10. PubMed ID: 33522895
[TBL] [Abstract][Full Text] [Related]
11. M6A RNA methylation-mediated dysregulation of AGAP2-AS1 promotes trastuzumab resistance of breast cancer.
Cai Y; Zheng H; Xu D; Xie J; Wang W; Liu Z; Zheng Z
Pharmacology; 2024 May; ():. PubMed ID: 38744264
[TBL] [Abstract][Full Text] [Related]
12. Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells.
Li W; Sun M; Zang C; Ma P; He J; Zhang M; Huang Z; Ding Y; Shu Y
Cell Death Dis; 2016 May; 7(5):e2225. PubMed ID: 27195672
[TBL] [Abstract][Full Text] [Related]
13. Exosome-mediated transfer of lncRNA‑SNHG14 promotes trastuzumab chemoresistance in breast cancer.
Dong H; Wang W; Chen R; Zhang Y; Zou K; Ye M; He X; Zhang F; Han J
Int J Oncol; 2018 Sep; 53(3):1013-1026. PubMed ID: 30015837
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging miR-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma.
Liu Z; Wang Y; Wang L; Yao B; Sun L; Liu R; Chen T; Niu Y; Tu K; Liu Q
J Exp Clin Cancer Res; 2019 May; 38(1):194. PubMed ID: 31088485
[TBL] [Abstract][Full Text] [Related]
15. LncRNA AGAP2-AS1 augments cell viability and mobility, and confers gemcitabine resistance by inhibiting miR-497 in colorectal cancer.
Hong S; Yan Z; Song Y; Bi M; Li S
Aging (Albany NY); 2020 Mar; 12(6):5183-5194. PubMed ID: 32202509
[TBL] [Abstract][Full Text] [Related]
16. Exosomal long noncoding RNA AGAP2-AS1 regulates trastuzumab resistance via inducing autophagy in breast cancer.
Qian X; Qu H; Zhang F; Peng S; Dou D; Yang Y; Ding Y; Xie M; Dong H; Liao Y; Han M
Am J Cancer Res; 2021; 11(5):1962-1981. PubMed ID: 34094664
[TBL] [Abstract][Full Text] [Related]
17. The Long Non-Coding RNA (lncRNA) AGAP2-AS1 is Upregulated in Ovarian Carcinoma and Negatively Regulates lncRNA MEG3.
Chen J; Peng X; Dai Y
Med Sci Monit; 2019 Jun; 25():4699-4704. PubMed ID: 31233485
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA AGAP2-AS1 exerts oncogenic properties in glioblastoma by epigenetically silencing TFPI2 through EZH2 and LSD1.
Luo W; Li X; Song Z; Zhu X; Zhao S
Aging (Albany NY); 2019 Jun; 11(11):3811-3823. PubMed ID: 31186379
[TBL] [Abstract][Full Text] [Related]
19. RREB1-induced upregulation of the lncRNA AGAP2-AS1 regulates the proliferation and migration of pancreatic cancer partly through suppressing ANKRD1 and ANGPTL4.
Hui B; Ji H; Xu Y; Wang J; Ma Z; Zhang C; Wang K; Zhou Y
Cell Death Dis; 2019 Feb; 10(3):207. PubMed ID: 30814490
[TBL] [Abstract][Full Text] [Related]
20. LncRNA DSCAM-AS1 interacts with YBX1 to promote cancer progression by forming a positive feedback loop that activates FOXA1 transcription network.
Zhang Y; Huang YX; Wang DL; Yang B; Yan HY; Lin LH; Li Y; Chen J; Xie LM; Huang YS; Liao JY; Hu KS; He JH; Saw PE; Xu X; Yin D
Theranostics; 2020; 10(23):10823-10837. PubMed ID: 32929382
[No Abstract] [Full Text] [Related]
[Next] [New Search]